The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...
AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...
That’s because it’s been five years since recommendations began changing about who should take the tiny little pill to prevent heart problems, and new data shows that 48% of adults still mistakenly ...
Aspirin is a blood thinner. Depending on your health condition, that can be beneficial or dangerous. Here's what medical experts recommend.
Approximately 48% of people think that the benefits of taking low-dose aspirin every day to lower their risk of heart attack or stroke outweigh the risks, but they’re wrong, according to a survey from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results